CytomX Therapeutics, Inc. (CTMX) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company that focuses on developing potent biologics designed to treat tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the…
Source: Yahoo Finance
Sector & Industry
CytomX Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
CytomX Therapeutics, Inc. at a Glance
| Company | CytomX Therapeutics, Inc. |
| Ticker | CTMX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $3.71 |
| Market cap | $808.41M |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$0.57 |
| 52-week high | $8.21 |
| 52-week low | $1.90 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 2.14 |
| Return on equity (ROE) | -37.75% |
| Debt-to-equity | 1.89% |
| Average volume | 3.96M |
| Shares outstanding | 217.90M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 69 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is CytomX Therapeutics, Inc.'s current P/E ratio?
- CytomX Therapeutics, Inc. (CTMX) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is CytomX Therapeutics, Inc.'s market capitalisation?
- CytomX Therapeutics, Inc.'s market cap is $808.41M based on our latest snapshot. See how it ranks by market cap →
- What is CTMX's 52-week range?
- Over the past 52 weeks, CTMX has traded between $1.90 and $8.21. What does the 52-week range mean? →
- How volatile is CytomX Therapeutics, Inc. compared to the market?
- CytomX Therapeutics, Inc. has a beta of 2.14, meaning it has historically moved more than the broader market. What does beta measure? →
- Does CytomX Therapeutics, Inc. pay a dividend?
- CytomX Therapeutics, Inc. does not currently pay a dividend according to our latest data.
- What exchange is CTMX listed on?
- CTMX is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is CytomX Therapeutics, Inc. in?
- CytomX Therapeutics, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
Need to convert currencies or units alongside this data? Our quick conversion tools are always on hand.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →